Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy

Circulation

Volumn 93, Issue 9, 1996, Pages 1640-1646

  Sawa, Yoshiki ^a   Taniguchi, Kazuhiro ^a   Kadoba, Keishi ^a   Nishimura, Motonobu ^a   Ichikawa, Hajime ^a   Amemiya, Akira ^a   Kuratani, Thoru ^a   Matsuda, Hikaru ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

cardioplegia; hypertrophy; leukocytes; reperfusion

Indexed keywords

CARDIOPLEGIC AGENT; DOPAMINE; MALONALDEHYDE; POTASSIUM ION;

ADULT; AGED; AORTA CLAMPING; AORTA VALVE REPLACEMENT; ARTICLE; BLOOD; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HEART PROTECTION; HUMAN; HUMAN TISSUE; LEUKOCYTE; NEUTROPHIL; OPEN HEART SURGERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY;

EID: 0029935761     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.9.1640     Document Type: Article

References (33)

1. Flameng W, Van der Vusse GJ, De Meyere R, Borgers M, Sergeant P, Vander Meersch E, Geboers J, Suy R. Intermittent aortic cross-clamping versus St. Thomas' Hospital cardioplegia in extensive aorta-coronary bypass grafting: a randomized clinical study. J Thorac Cardiovasc Surg. 1984;88:164-173.
2. Conti RV, Bertranou EG, Blackstone EH. Cold cardioplegia versus hypothermia for myocardial protection. J Thorac Cardiovasc Surg. 1978;76:577-589.
3. Wechsler AS. Deficiencies of cardioplegia: the hypertrophied ventricle. In: Engelman RM, Levitsky S, eds. A Textbook of Clinical Cardioplegia. New York, NY: Futura Publishing Co; 1982:381-390.
4. Mundth ED, Goel IP, Morgan RJ, McEnany MT, Austen WG. Effect of potassium cardioplegia and hypothermia on left ventricular function in hypertrophied and nonhypertrophied hearts. Surg Forum. 1975;26:257-258.
5. Matsuda H, Maeda S, Hirose H, Nakano S, Shirakura R, Kaneko M, Kadoba K, Kawashima Y. Optimum dose of cold potassium cardioplegia for patients with chronic aortic valve disease: determination by left ventricular mass. Ann Thorac Surg. 1986;41:22-26.
6. Warner KG, Khuri SF, Kloner RA. Structural and metabolic correlates of cell injury in the hypertrophied myocardium during valve replacement. J Thorac Cardiovasc Surg. 1987;93:741-754.
7. Wexler LF, Lorell BH, Momomura S. Enhanced sensitivity to hypoxia-induced diastolic dysfunction in pressure-overload left ventricular hypertrophy. Circ Res. 1988;62:766-775.
8. Eberil FR, Apstein CS, Nagoy S. Exacerbation of left ventricular ischemic diastolic dysfunction by pressure-overload hypertrophy: modification by specific inhibition of cardiac angiotensin converting enzyme. Circ Res. 1992;70:931-943.
9. Hill JH, Ward PA. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med. 1972;133:885-900.
10. Engler RL, Schmid-Schoenbein GW, Pavelee RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol. 1983;111:98-111.
11. Romson JL, Hook BG, Kunkel SL, Abrams GD, Shork A, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 1983;67:1016-1023.
12. Mehta JL, Nichols WW, Mehta P. Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. J Am Coll Cardiol. 1988;11:1309-1316.
13. Forman MB, Puett DW, Virmani R. Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications. J Am Coll Cardiol. 1989;13:450-459.
14. Simpson PJ, Todd RF III, Fantone JC, Gallagher KP, Lee KA, Tamura Y, Cronin M, Lucchesi BR. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function. Circulation. 1990;81:226-237.
15. Sawa Y, Matsuda H, Shimazaki Y, Kaneko M, Nishimura M, Amemiya A, Sakai K, Nakano S. Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1994;108:1125-1131.
16. Rackley CE, Dodge HT, Coble YD Jr, Hay RE. A method for determining left ventricular mass in man. Circulation. 1964;29: 666-671.
17. Taniguchi K, Nakano S, Kawashima Y, Sakai K, Kawamoto T, Sakaki S, Kobayashi J, Morimoto S, Matsuda H. Left ventricular ejection performance, wall stress, and contractile state in aortic regurgitation before and after aortic valve replacement. Circulation. 1990;82:798-802.
18. Wynne J, Green LH, Grossman W, Mann T, Levin D. Estimation of left ventricular volumes in man from biplane cineangiograms filmed in oblique projections. Am J Cardiol. 1978;41:727-732.
19. Sawa Y, Matsuda H, Shimazaki Y, Hirose H, Kadoba K, Takami H, Nakada T, Kawashima Y. Ultrastructural assessment of the infant myocardium receiving crystalloid cardioplegia. Circulation. 1987; 76(suppl V):V-141-V-145.
20. Schaper J, Walter P, Scheld H, Hehrlein F. The effect of retrograde perfusion of cardioplegic solution in cardiac operations. J Thorac Cardiovasc Surg. 1985;90:882-887.
21. Kuratani T, Matsuda H, Sawa Y. Experimental study in a rabbit model of ischemia-reperfusion injury during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1992;103:564-568.
22. Engler RL, Dahgren MD, Morris DD, Peterson MA, Schmid-Schoenbein G. Role of leukocytes in response to acute myocardial ischemia and flow in dogs. Am J Physiol. 1986;251:H314-H323.
23. Litt M, Jeremy RM, Weisman HF, Winkelstein JA, Becker LC. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia: evidence for neutrophil-mediated reperfusion injury. Circulation. 1989;80:1816-1827.
24. Sheridan FM, Dauber IM, McMurtry IF, Lesnefsky EJ, Horwitz LD. Role of leukocytes in coronary vascular endothelial injury due to ischemia and reperfusion. Circ Res. 1991;69:1566-1574.
25. Jeremy RW, Becker LC. Neutrophil depletion does not prevent myocardial dysfunction after brief coronary occlusion. J Am Coll Cardiol. 1989;13:1155-1163.
26. Sawa Y, Shimazaki Y, Kadoba K, Masai T, Fukuda H, Ohata T, Taniguchi K, Matsuda H. Attenuation of cardiopulmonary bypass derived inflammatory reactions reduces myocardial reperfusion injury in open heart surgery. J Thorac Cardiovasc Surg. 1996;111: 29-35.
27. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990;87:1620-1624.
28. Buckberg GD. Studies of controlled reperfusion after ischemia, I: when is cardiac muscle damaged irreversibly? J Thorac Cardiovasc Surg. 1986;92:483-487.
29. Follete DM, Fey K, Buckberg GD. Reducing post-ischemic damage by temporary modification of reperfusate calcium, potassium, pH and osmolarity. J Thorac Cardiovasc Surg. 1981;82:221-238.
30. Teoh KH, Christakis GT, Weisel RD. Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg. 1986;91:888-895.
31. Schaper J, Schaper W. Reperfusion of ischemic myocardium: ultrastructure and histochemical aspects. J Am Coll Cardiol. 1983;1: 1037-1046.
32. Pearl EM, Drinkwater DC, Laks H. Leukocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury. J Surg Res. 1992;52:298-308.
33. Pearl EM, Drinkwater DC, Laks H. Leukocyte depleted reperfusion of transplanted human hearts: a randomized, double-blind clinical trial. J Heart Lung Transplant. 1992;11:1082-1092.